Bodd is entering new territory.
What’s happening: The Aussie 3D body-scanning startup raised A$15M ($10M) to accelerate global expansion, pushing its valuation to $73M as it moves deeper into health and wellness.
In a flash. Originally built for apparel fittings, Bodd’s scanners now capture high-fidelity vitals—from body fat and water retention to blood pressure and heart rate—in under 90 seconds.
With $25M raised to date, it’s targeting weight management next, deploying across pharmacies in 2026 to give GLP-1 patients precise, longitudinal data.
Incognito. Unbundling from the clinic, AI-enabled biometrics are moving into everyday life, with next-gen scans becoming core infrastructure for gyms, medspas, and longevity clinics.
Powering check-ins for EōS and Equinox, BIA platforms Evolt and InBody are also entering medicine, while AI analysis from DexaFit, Fitnescity, and Springbok augment sports science.
Meanwhile, 3D models from the likes of Spren, 3DLOOK, Fit3D, Noom x Prism, and Technogym’s Checkup are helping GLP-1 users preserve muscle, optimize dosing, and monitor composition shifts far beyond BMI.
Punchline: As weight loss, preventative care, and performance converge, Bodd and other high-tech scanners are unlocking diagnostics that power the next era of personalized health.
